Incorporated in 2000, Zenith Drugs Limited is a pharmaceutical company specializing in manufacturing and trading medicines, including generic drugs.
Zenith Drugs' board made key moves: re-designating Ajay Singh Dassundi to Non-Executive Director. The company also allotted 1.61 million convertible warrants to promoters at Rs 43.50 each, initially raising ₹1.75 Cr. This private placement could inject up to ₹6.99 Cr total.
Zenith Drugs' board re-designated Mr. Ajay Singh Dassundi to Non-Executive Director. The company also approved allotting 16.09 lakh convertible warrants to promoters at Rs 43.50 each, aiming to raise up to Rs 7.00 Cr. An initial 25% payment of Rs 1.75 Cr has been received.